The future of gene therapy. Biotechnology Healthc. June 2005; 2(3): 52-54, 56-60. Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564347/ This article discusses both the history and potential future of gene therapy. The author asserts that, in its current formulation, gene therapy is a well-conceived and clearly implemented theory. This is not a criticism but rather the current situation in an extremely complex technology that is still in its formative years. After all, only five years have passed since the invention of gene therapy was convincingly confirmed to provide, if not a cure, at least long-term therapeutic impact against severe X-linked joint immunodeficiency. . This article provides an overview of current trends in X-linked severe joint immunodeficiency. gene therapy because it offers a critical analysis of gene therapy both at the beginning and in its current state. It also explores the situation of patients who have undergone gene therapy to determine whether this therapy was successful or not. This helps to establish why this mode of therapy has been accepted more slowly than initially.